Highly efficient in vitro and in vivo delivery of functional RNAs using new versatile MS2-chimeric retrovirus-like particles.

Prel A, Caval V, Gayon R, Ravassard P, Duthoit C, Payen E, Maouche-Chretien L, Creneguy A, Nguyen TH, Martin N, Piver E, Sevrain R, Lamouroux L, Leboulch P, Deschaseaux F, Bouillé P, Sensébé L, Pagès JC

Open source

DOI
10.1038/mtm.2015.39
Published
2015
Container
Molecular therapy. Methods & clinical development
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/mtm.2015.39,
  title = {Highly efficient in vitro and in vivo delivery of functional RNAs using new versatile MS2-chimeric retrovirus-like particles.},
  author = {Prel A and Caval V and Gayon R and Ravassard P and Duthoit C and Payen E and Maouche-Chretien L and Creneguy A and Nguyen TH and Martin N and Piver E and Sevrain R and Lamouroux L and Leboulch P and Deschaseaux F and Bouillé P and Sensébé L and Pagès JC},
  year = {2015},
  journal = {Molecular therapy. Methods \& clinical development},
  doi = {10.1038/mtm.2015.39},
  url = {https://doi.org/10.1038/mtm.2015.39}
}

RIS

TY  - JOUR
TI  - Highly efficient in vitro and in vivo delivery of functional RNAs using new versatile MS2-chimeric retrovirus-like particles.
AU  - Prel A
AU  - Caval V
AU  - Gayon R
AU  - Ravassard P
AU  - Duthoit C
AU  - Payen E
AU  - Maouche-Chretien L
AU  - Creneguy A
AU  - Nguyen TH
AU  - Martin N
AU  - Piver E
AU  - Sevrain R
AU  - Lamouroux L
AU  - Leboulch P
AU  - Deschaseaux F
AU  - Bouillé P
AU  - Sensébé L
AU  - Pagès JC
PY  - 2015
JO  - Molecular therapy. Methods & clinical development
DO  - 10.1038/mtm.2015.39
UR  - https://doi.org/10.1038/mtm.2015.39
ER  - 

APA

A, P., V, C., R, G., P, R., C, D., E, P., L, M., A, C., TH, N., N, M., E, P., R, S., L, L., P, L., F, D., P, B., L, S., & JC, P. (2015). Highly efficient in vitro and in vivo delivery of functional RNAs using new versatile MS2-chimeric retrovirus-like particles.. Molecular therapy. Methods & clinical development. https://doi.org/10.1038/mtm.2015.39

Source records